Published in:
01-02-2021 | Pituitary Adenoma
Machine learning in predicting early remission in patients after surgical treatment of acromegaly: a multicenter study
Published in: Pituitary | Issue 1/2021
Login to get accessAbstract
Purpose
Accurate prediction of postoperative remission is beneficial for effective patient-physician communication in acromegalic patients. This study aims to train and validate machine learning prediction models for early endocrine remission of acromegalic patients.
Methods
The training cohort included 833 patients with growth hormone (GH) secreting pituitary adenoma from 2010 to 2018. We trained a partial model (only using pre-operative variables) and a full model (using all variables) to predict off-medication endocrine remission at six-month follow-up after surgery using multiple algorithms. The models were validated in 99 prospectively collected patients from a second campus and 52 patients from a third institution.
Results
C-statistic and the accuracy of the best partial model was 0.803 (95% CI 0.757–0.849) and 72.5% (95% CI 67.6–77.5%), respectively. C-statistic and the accuracy of the best full model was 0.888 (95% CI 0.861–0.914) and 80.3% (95% CI 77.5–83.1%), respectively. The c-statistics (and accuracy) of using only Knosp grade, total resection, or postoperative day 1 GH level as the single predictor were lower than our partial model or full model (p < 0.001). C-statistics remained similar in the prospective cohort (partial model 0.798, and full model 0.903) and in the external cohort (partial model 0.771, and full model 0.871). A web-based application integrated with the trained models was published at https://deepvep.shinyapps.io/Acropred/.
Conclusion
We developed and validated interpretable and applicable machine learning models to predict early endocrine remission after surgical resection of a GH-secreting pituitary adenoma. Predication accuracy of the trained models were better than those using single variables.